Top Markets
#1 GEKKO GEKKO +50.71%
#2 ADO Protocol ADO Protocol +38.43%
#3 Helium Helium +32.25%
#4 Pons Pons +29.76%
#5 TENDIES TENDIES +22.22%
#6 CZ'S Dog CZ'S Dog +20.99%
#7 Giggle Fund Giggle Fund +20.95%
#8 龙虾 (Lobster) 龙虾 (Lobster) +19.51%
#9 Main Street Yield Main Street Yield +17.48%
#10 o1.exchange o1.exchange +17.25%
Coin of the day
GEKKO GEKKO
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Seaport Therapeutics, Inc. Common Stock Seaport Therapeutics, Inc. Common Stock

Seaport Therapeutics, Inc. Common Stock

SPTX
Clasificación en acciones #8294
Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise... Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise currently undergoing clinical trials, focused on creating groundbreaking treatments for neuropsychiatric conditions. The company is primarily engaged in tackling disorders like depression and anxiety, utilizing its unique Glyph technology. This exclusive platform is engineered to allow for oral administration of drugs, circumventing initial metabolic processing in the liver, and thereby reducing the risk of liver enzyme elevations, hepatotoxicity, and other potential adverse reactions. Every therapeutic agent in their pipeline incorporates this advanced platform, with all research and development efforts exclusively dedicated to neuropsychiatric applications. Founded in 2024 and situated in Boston, Massachusetts, the company connects with medical professionals and influential experts across the healthcare and neuropsychiatric sectors.
Precio por acción
$24.37
Última sincronización: 2026-08-28
Capitalización bursátil
$1.30B
Cambio (1 día)
-7.16%
Cambio (1 año)
-
País
US
Comercio Seaport Therapeutics, Inc. Common Stock (SPTX)

Categoría

Healthcare
Ganancias de Seaport Therapeutics, Inc. Common Stock (SPTX)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Seaport Therapeutics, Inc. Common Stock, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Seaport Therapeutics, Inc. Common Stock desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH